Home › NDC Lookup › RxCUI directory › RxCUI 1147223

Vemurafenib 240 MG Oral Tablet — RxCUI 1147223

RxNorm drug concept · Semantic clinical drug
RxCUI 1147223 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1147223
Official nameVemurafenib 240 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)24 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vemurafenib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zelboraf is used for melanoma that has spread or can't be removed by surgery, and for Erdheim-Chester disease. Your tumor has to carry a BRAF mutation. Testing confirms that before...
  • Swallow the tablets whole about every 12 hours, with or without food. Don't crush or chew them. If you vomit, skip the extra dose and take the next one on time. A missed dose can b...
  • Joint pain, rash, hair loss, tiredness, nausea, itching and sun sensitivity are common. Skin growths can also appear. Tell your care team about anything that bothers you, as doses...
  • This medicine can cause new skin cancers, heart rhythm changes, and liver and kidney problems. That's why you'll have skin exams, ECGs and blood tests. Call me or your doctor about...
📖 Read our full Vemurafenib guide →

🕸️ Concept Web — How Vemurafenib 240 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vemurafenib 240 MG Oral Tablet RxCUI 1147223

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vemurafenib 1147220
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zelboraf 1147224
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vemurafenib Oral Tablet 1147222
    • Vemurafenib Oral Product 1160508
    • Vemurafenib Pill 1160509
    • Vemurafenib Oral Tablet [Zelboraf] 1147227
    • Zelboraf Oral Product 1187234
    • Zelboraf Pill 1187235
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vemurafenib 240 MG SCDC · 1147221
  • Vemurafenib Oral Tablet SCDF · 1147222
  • Vemurafenib Oral Product SCDG · 1160508
  • Vemurafenib Pill SCDG · 1160509

Brand-Name Concepts

  • Vemurafenib 240 MG Oral Tablet [Zelboraf] SBD · 1147228
  • Vemurafenib 240 MG [Zelboraf] SBDC · 1147225
  • Vemurafenib Oral Tablet [Zelboraf] SBDF · 1147227
  • Zelboraf Oral Product SBDG · 1187234
  • Zelboraf Pill SBDG · 1187235
  • Zelboraf BN · 1147224

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1147223 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0090-02 1 BOTTLE, PLASTIC in 1 CARTON (50242-090-02) / 112 TABLET,... ZELBORAF Genentech, Inc. 2015-09-08
Observed labelers: Genentech, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.